US FDA Explains How It Is Embracing Remote Assessments Post-Pandemic

 
• By Bowman Cox

Agency provides new details on plans for various remote methods of assessing manufacturing establishments that became popular when investigators were prevented by COVID-19 pandemic travel restrictions from visiting sites in person.

Virtual inspection
when the fda will show up remotely • Source: Shutterstock

More from Manufacturing

More from Compliance